New England Biolabs Acquires Fluorogenics Limited

Fulgent Genetics Acquires Fulgent Pharma

November 7, 2022

Biotechnology

Fulgent Genetics completed the acquisition of Fulgent Pharma Holdings for approximately $100 million in a combination of cash and Fulgent common stock. The deal integrates Fulgent Pharma’s nanoencapsulation drug-delivery platform and clinical-stage oncology pipeline with Fulgent Genetics’ diagnostics capabilities to create a vertically integrated precision-medicine offering focused on cancer.

Lantheus Acquires Life Molecular Imaging from Life Healthcare

July 22, 2025

Healthcare Services

Lantheus Holdings, Inc. completed the acquisition of Life Molecular Imaging Ltd., a subsidiary of Life Healthcare Group Holdings Ltd., gaining the Neuraceq (florbetaben F18) commercial product, expanded Alzheimer’s radiodiagnostic infrastructure, and additional R&D capabilities. As part of the transaction, Dr. Ludger Dinkelborg (formerly CEO of Life Molecular) will join Lantheus as Head of Research & Development, reporting to the CEO.

Illumina Acquires Fluent BioSciences

July 9, 2024

Biotechnology

Illumina, Inc. has acquired Fluent BioSciences to integrate Fluent's PIPseq single-cell technology into Illumina's product portfolio and accelerate its multiomics capabilities. The acquisition, which closed July 9, 2024 and was funded with cash on hand, brings Fluent's accessible, scalable single-cell chemistry and the Fluent team into Illumina to expand end-to-end single-cell solutions for research and applied customers.

Bacharach (FFL Partners) Acquires Neutronics

July 3, 2018

Manufacturing

Bacharach, a portfolio company of FFL Partners, has acquired Neutronics, Inc., a provider of refrigerant and gas analysis instrumentation. BDO Capital served as exclusive financial advisor to Neutronics and worked with the company's shareholders and management through the sale process; the acquisition expands Bacharach/FFL's capabilities in gas/refrigerant analysis for HVAC-R, automotive and semiconductor end markets.

Vector Laboratories Acquires Click Chemistry Tools and Fluoroprobes

March 6, 2023

Biotechnology

Vector Laboratories, a portfolio company of Thompson Street Capital Partners, has acquired Click Chemistry Tools (Scottsdale, AZ) and Fluoroprobes to expand its manufacturing, bioconjugation and labeling capabilities. The add-on acquisitions, with terms undisclosed, are intended to accelerate commercialization of protein detection technologies and increase security of supply for biopharma, diagnostics and life-science customers.

Inhance Technologies Acquires Fluor Technik System GmbH

October 16, 2019

Manufacturing

Inhance Technologies, a portfolio company of Aurora Capital Partners, has acquired Fluor Technik System GmbH (FTS), a Lauterbach-based provider of post-mold fluorination and plastic surface modification solutions. The acquisition gives Inhance a strategic European presence and expands its fluorination capabilities to better serve customers across medical devices, consumer products, automotive and other end markets.